Discordant Humoral and Cellular Immune Responses to Cytomegalovirus (CMV) in Glioblastoma Patients Whose Tumors are Positive for CMV

Rahbar et al., OncoImmunology (2015) - PMID: n.a.

Product(s) used in this publication: PepMix™ Peptide Pools

Sorry, currently there is no abstract available.

Stay in touch and be the first to receive the latest news!